, Volume 91, Issue 1, pp 14–19 | Cite as

Rewarding properties of β-endorphin as measured by conditioned place preference

  • M. Amalric
  • E. J. Cline
  • J. L. MartinezJr.
  • F. E. Bloom
  • G. F. Koob
Original Investigations


The role of β-endorphin as a possible mediator in the reinforcing properties of opiates was investigated using a conditioned place preference paradigm. Heroin, a synthetic opiate known to have reinforcing properties, produced a strong preference for an environment previously paired with heroin injection at all doses tested (0.25, 0.5, 1.0, 2.0 mg/kg SC). No such place preference was observed following saline injections. Rats also showed dose-dependent place preference for the environment paired with β-endorphin when injected intracerebroventricularly (significant dose was 2.5 μg). At higher doses (5.0 and 10.0 μg) rats showed no preference for the paired environment, but were catatonic. Pretreatment with naloxone (0.04, 0.2, 1.0 mg/kg SC) attenuated the rewarding effect of β-endorphin (2.5 μg) at all doses tested. The lowest dose of naloxone which had no aversive effect when tested alone could also significantly block the positive effect of β-endorphin. The reinforcing dose of β-endorphin (2.5 μg) also produced an increase in locomotor activity, when tested in photocell cages. This suggests that the hyperactivity induced by β-endorphin may contribute to the preference for an environment previously paired with the same drug. The reinforcing effect of β-endorphin is most probably mediated by the mu and/or delta opioid subtype receptor, since β-endorphin has a high affinity for these receptors. These results demonstrate positive reinforcing properties of β-endorphin in the central nervous system.

Key words

Place preference Heroin β-endorphin Naloxone Reward Rat 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Amalric M, Koob GF (1985) Low doses of methylnaloxonium in the nucleus accumbens antagonize hyperactivity induced by heroin in the rat. Pharmacol Biochem Behav 23:411–415Google Scholar
  2. Bardo MT, Miller JS, Neisewander JL (1984) Conditioned place preference with morphine: The effects of extinction training on the reinforcing CR. Pharmacol Biochem Behav 21:545–543Google Scholar
  3. Belluzzi JD, Stein L (1977) Enkephalin may mediate euphoria and drive-reduction reward. Nature 266:556–558Google Scholar
  4. Blander A, Hunt T, Blair R, Amit Z (1984) Conditioned place preference: An evaluation of morphine positive reinforcing properties. Psychopharmacology 84:124–127Google Scholar
  5. Bloom FE, Segal D, Ling N, Guillemin R (1976) Endorphins: profound behavioral effects in rats suggest new etiological factors in mental illness. Science 194:630–632Google Scholar
  6. Bozarth MA, Wise RA (1981a) Heroin reward is dependent on a dopaminergic substrate. Life Sci 29:1881–1886Google Scholar
  7. Bozarth MA, Wise RA (1981b) Intracranial self-administration of morphine into the ventral tegmental area in rats. Life Sci 28:551–555Google Scholar
  8. Broekkamp CL, Phillips AG, Cools AR (1979) Facilitation of self-stimulation behavior following intracerebral microinjections of opioids into the ventral tegmental area. Pharmacol Biochem Behav 11:289–295Google Scholar
  9. Browne RG, Derrington DC, Segal DS (1979) Comparison of opiate — and opioid — peptide induced immobility. Life Sci 24:933–942Google Scholar
  10. Cappell H, LeBlanc AE, Endrenyi L (1973) Aversive conditioning by psychoactive drugs: effects of morphine, alcohol and chlordiazepoxide. Psychopharmacology 29:239–246Google Scholar
  11. Elde R, Hokfelt T, Johansson O, Terenius L (1976) Immunohistochemical studies using antibodies to leucine-enkephalin: initial observations on the nervous system of the rat. Neuroscience 1:349–351Google Scholar
  12. Goeders NE, Lane JD, Smith JE (1984) Self-administration of methionine enkephalin into the nucleus accumbens. Pharmacol Biochem Behav 20:451–455Google Scholar
  13. Inturrisi CE, Schultz M, Shin S, Umans JG, Angel L, Simon EJ (1983) Evidence from opiate binding studies that heroin acts through its metabolites. Life Sci 33:773–776Google Scholar
  14. Jacquet YF, Marks N (1976) The c-fragment of β-lipotropin: An endogenous neuroleptic or antipsychogen? Science 194:632–635Google Scholar
  15. Katz RJ, Gormezano G (1979) A rapid inexpensive technique for assessing the reinforcing effects of opiate drugs. Pharmacol Biochem Behav 11:231–233Google Scholar
  16. Kelley AE, Stinus L, Iversen SD (1980) Interaction betweend-alamet-enkephalin, A 10 dopaminergic neurones and spontaneous behavior in the rat. Behav Brain Res 1:3–24Google Scholar
  17. Kelsey JE, Belluzzi JD, Stein L (1984) Does naloxone suppress self-stimulation by decreasing reward or by increasing aversion? Brain Res 307:55–59Google Scholar
  18. Kumar R (1972) Morphine dependence in rats: Secondary reinforcement from environmental stimuli. Psychopharmacologia 25:332–338Google Scholar
  19. Loh HH, Tseng LF, Wei ET, Li CH (1976) β-endorphin is a potent analgesic agent. Proc Natl Acad Sci USA 73:2835–2898Google Scholar
  20. Mucha FR, Iversen SD (1984) Reinforcing properties of morphine and naloxone revealed by conditioned place preferences: A procedural examination. Psychopharmacology 82:241–247Google Scholar
  21. Mucha RF, Herz A (1985) Motivational properties of kappa and mu opioid receptor agonists studied with place and taste preference conditioning. Psychopharmacology 86:274–280Google Scholar
  22. Mucha RF, Van der Kooy D, O'Shaughressy M, Bucenieks P (1982) Drug reinforcement studied by use of place conditioning in rat. Brain Res 243:91–105Google Scholar
  23. Mucha RF, Millan MJ, Herz A (1985) Aversive properties of naloxone in non-dependent (naive) rats may involve blockade of central β-endorphin. Psychopharmacology 86:281–285Google Scholar
  24. Olds ME (1982) Reinforcing effects of morphine in the nucleus accumbens. Brain Res 237:429–440Google Scholar
  25. Olds ME, Williams KN (1980) Self-administration ofd-ala 2-metenkephalinamide at hypothalamic self-stimulation sites. Brain Res 194:155–170Google Scholar
  26. Phillips AG, LePiane FG (1980) Reinforcing effects of morphine microinjection into the ventral tegmental area. Pharmacol Biochem Behav 12:965–968Google Scholar
  27. Phillips AG, LePiane FG (1982) Reward produced by microinjection ofd-ala-met-enkephalinamide into ventral tegmental area. Behav Brain Res 5:225–229Google Scholar
  28. Phillips AG, LePiane FG, Fibiger HC (1983) Dopaminergic mediation of reward produced by direct injection of enkephalin into the vental tegmental area of the rat. Life Sci 33:2505–2511Google Scholar
  29. Rossi NA, Reid LD (1976) Affective states associated with morphine injection. Physiol Psychol 4:269–274Google Scholar
  30. Schenk S, Ellison F, Hunt T, Amit Z (1985) An examination of heroin conditioning in preferred and non preferred environments and in differentially housed mature and immature rats. Pharmacol Biochem Behav 22:215–220Google Scholar
  31. Segal DS, Browne RG, Arnsten A, Derrington DC, Bloom FE, Guillemin R, Ling N (1979) Characteristics of β-endorphin induced behavioral activation and immobilization. In: Usdin E, Bunney WE, Kline NS (eds) Endorphins in mental health research. MacMillan, London, pp 307–324Google Scholar
  32. Sherman JE, Pickman C, Rice A, Liebeskind JC, Homan EW (1980) Rewarding and aversive effects of morphine: Temporal and pharmacological properties. Pharmacol Biochem Behav 13:501–505Google Scholar
  33. Spyraki C, Fibiger HC, Phillips AG (1983) Attenuation of heroin reward in rats by disruption of the mesolimbic dopamine system. Psychopharmacology 79:278–283Google Scholar
  34. Stapleton JM, Lind MD, Merriman VJ, Bozarth MA, Reid LD (1979) Affective consequences and subsequent effects on morphine self-administration of d-ala2-methionine enkephalin. Physiol Psychol 7:146–152Google Scholar
  35. Stein L, Belluzzi JD (1978) Brain endorphins and the sense of well-being: A psychobiological hypothesis. Adv Biochem Psychopharm 18:299–311Google Scholar
  36. Stinus L, Koob GF, Ling N, Bloom FE, LeMoal M (1980) Locomotor activation induced by infusion of endorphins into the ventral tegmental area: Evidence for opiate-dopamine interactions. Proc Natl Acad Sci USA 77:2323–2327Google Scholar
  37. Swerdlow NR, Koob GF (1984) Restrained rats learn amphetamine conditioned locomotion, but not place preference. Psychopharmacology 84:163–166Google Scholar
  38. Tseng LF, Nei ET, Loh HH, Choh HL (1980) β-endorphin: central sites of analgesia, catalepsy and body temperature changes in rats. J Pharmacol Exp Ther 214:328–332Google Scholar
  39. Vaccarino FJ, Bloom FE, Koob GF (1985) Blockade of nucleus accumbens opiate receptors attenuates intravenous heroin reward in the rat. Psychopharmacology 86:37–42Google Scholar
  40. Van der Kooy D, Mucha RF, O'Shaughnessey M, Bucenieks P (1982) Reinforcing effects of brain microinjections of morphine revealed by conditioned place preference. Brain Res 243:107–117Google Scholar
  41. Way EL, Adler TK (1960) The pharmacologic implications of the fate or morphine and its surrogate. Pharmacol Rev 12:383–446Google Scholar
  42. Wolfswinkel L, Van Ree JM (1985) Differential effect of naloxone on food and self-stimulation rewarded acquisition of a behavioral response pattern. Pharmacol Biochem Behav 23:199–202Google Scholar
  43. Zukin RS, Zukin SR (1984) The case for multiple opiate receptors. TINS 7:160–164Google Scholar

Copyright information

© Springer-Verlag 1987

Authors and Affiliations

  • M. Amalric
    • 1
  • E. J. Cline
    • 1
  • J. L. MartinezJr.
    • 2
  • F. E. Bloom
    • 1
  • G. F. Koob
    • 1
  1. 1.Division of Preclinical Neuroscience and EndocrinologyScripps Clinic and Research FoundationLa JollaUSA
  2. 2.Department of PsychologyUniversity of California BerkeleyBerkeleyUSA

Personalised recommendations